Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of clinical presentation of respiratory tract infections in H1N1/09-positive and H1N1/09-negative patients.
Crisinel PA, Barazzone C, Kaiser L, L'Huillier AG, Taguebue J, Wagner N, Delcò C, Siegrist CA, Posfay-Barbe KM; H1N1 Pediatric Epidemiology Study Group. Crisinel PA, et al. Among authors: kaiser l, l huillier ag. Eur J Pediatr. 2012 Jan;171(1):159-66. doi: 10.1007/s00431-011-1513-7. Epub 2011 Jun 15. Eur J Pediatr. 2012. PMID: 21674140
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children.
Meier S, Bel M, L'huillier A, Crisinel PA, Combescure C, Kaiser L, Grillet S, Pósfay-Barbe K, Siegrist CA; H1N1 Epidemiology Study Group of Geneva. Meier S, et al. Among authors: kaiser l, l huillier a. Vaccine. 2011 Apr 27;29(19):3548-57. doi: 10.1016/j.vaccine.2011.02.094. Epub 2011 Mar 17. Vaccine. 2011. PMID: 21419775
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.
Gabay C, Bel M, Combescure C, Ribi C, Meier S, Posfay-Barbe K, Grillet S, Seebach JD, Kaiser L, Wunderli W, Guerne PA, Siegrist CA; H1N1 Study Group. Gabay C, et al. Among authors: kaiser l. Arthritis Rheum. 2011 Jun;63(6):1486-96. doi: 10.1002/art.30325. Arthritis Rheum. 2011. PMID: 21384334 Free article. Clinical Trial.
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients.
Hottinger AF, George AC, Bel M, Favet L, Combescure C, Meier S, Grillet S, Posfay-Barbe K, Kaiser L, Siegrist CA, Dietrich PY; H1N1 Study Group. Hottinger AF, et al. Among authors: kaiser l. Oncologist. 2012;17(3):436-45. doi: 10.1634/theoncologist.2011-0342. Epub 2012 Feb 21. Oncologist. 2012. PMID: 22357731 Free PMC article. Clinical Trial.
Pneumonia and pericarditis in a child with HRV-C infection: a case report.
Tapparel C, L'Huillier AG, Rougemont AL, Beghetti M, Barazzone-Argiroffo C, Kaiser L. Tapparel C, et al. Among authors: kaiser l, l huillier ag. J Clin Virol. 2009 Jun;45(2):157-60. doi: 10.1016/j.jcv.2009.03.014. Epub 2009 May 7. J Clin Virol. 2009. PMID: 19427260 Free PMC article.
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients.
Mohty B, Bel M, Vukicevic M, Nagy M, Levrat E, Meier S, Grillet S, Combescure C, Kaiser L, Chalandon Y, Passweg J, Siegrist CA, Roosnek E; Blood and Marrow Transplant Program; Geneva University Hospitals H1N1 study group. Mohty B, et al. Among authors: kaiser l. Haematologica. 2011 Jun;96(6):896-904. doi: 10.3324/haematol.2011.040386. Epub 2011 Mar 21. Haematologica. 2011. PMID: 21422117 Free PMC article. Clinical Trial.
1,551 results